Because drugs and medical devices are often sourced, processed, and manufactured in multiple countries, manufacturers are often faced with difficult challenges in determining the country of origin for their products. As detailed in the article “Origin of the Pieces: How to Determine a Pharmaceutical Product’s ‘Country of Origin,'” written by Reed Smith lawyers Jeffrey Orenstein and Lorraine Campos, a variety of factors must be taken into consideration when answering the country of origin question for a pharmaceutical product. The alert is available on our Life Sciences Legal Update blog.
